Premium Nahrungsergänzungsmittel | artgerecht

TB-500 – Peptide for Regeneration and Tissue Healing

TB-500 is a synthetic peptide derived from the naturally occurring protein Thymosin Beta-4, studied for its potential to support tissue healing, regeneration, and anti-inflammatory effects.

Regular tips about health Regular tips about health

Things worth knowing about "TB-500"

TB-500 is a synthetic peptide derived from the naturally occurring protein Thymosin Beta-4, studied for its potential to support tissue healing, regeneration, and anti-inflammatory effects.

What is TB-500?

TB-500 is a synthetic peptide derived from Thymosin Beta-4 (TB4), a protein that occurs naturally in virtually all human cells. It represents a shorter, biologically active fragment of the full Thymosin Beta-4 molecule, designed to replicate its key regenerative and anti-inflammatory properties. Thymosin Beta-4 plays a fundamental role in cell migration, tissue repair, and the regulation of inflammatory responses throughout the body.

TB-500 is primarily discussed in the context of sports science, regenerative medicine, and veterinary medicine. It is not approved as a pharmaceutical drug for human use but is actively studied in research settings worldwide.

Mechanism of Action

The primary mechanism of TB-500 involves its ability to bind to actin, a structural protein essential for cell movement and growth. Through this interaction, TB-500 promotes several key biological processes:

Cell migration: TB-500 stimulates the movement of cells toward injured tissue, accelerating the wound-healing process.
Angiogenesis: It promotes the formation of new blood vessels, improving oxygen and nutrient delivery to damaged areas.
Anti-inflammatory effects: TB-500 helps modulate inflammatory responses, reducing excessive or chronic inflammation.
Tissue regeneration: It supports the repair of muscle, tendon, ligament, and cartilage tissue.

Areas of Application

Recovery from Injuries

TB-500 is primarily discussed as a means of accelerating recovery from muscle, tendon, and ligament injuries. In veterinary medicine, particularly in racehorses, TB-500 has been used to support athletic recovery and performance.

Inflammatory Conditions

Due to its anti-inflammatory properties, TB-500 is also being investigated in preclinical studies for chronic inflammatory and autoimmune conditions.

Cardiac Muscle Regeneration

Research suggests that Thymosin Beta-4 and its derivatives, including TB-500, may have protective effects on cardiac muscle cells and could support regenerative processes following a heart attack.

Administration and Dosage

TB-500 is typically administered via subcutaneous injection. Since it is not an approved pharmaceutical for human use, there are no officially established dosage guidelines. In preclinical studies and veterinary applications, doses in the microgram to milligram range have been used.

Important: The use of TB-500 in humans outside of controlled clinical trials is considered experimental and is not legally approved in many countries.

Side Effects and Safety

Since clinical human studies remain limited, the complete side effect profile of TB-500 is not yet fully established. Based on available preclinical data and anecdotal reports, the following risks have been identified:

Local injection site reactions (redness, swelling)
Potential promotion of tumor growth due to increased angiogenesis (theoretical risk)
Interactions with other medications not yet fully characterized
Quality and purity risks associated with unregulated sources

Legal Status and Anti-Doping

TB-500 is listed on the World Anti-Doping Agency (WADA) Prohibited List and is banned for use by competitive athletes. It is classified as a peptide hormone and growth factor, placing it firmly within the category of prohibited substances in sport. Athletes must familiarize themselves with the legal regulations in their country and the applicable anti-doping rules before considering any use.

Current State of Research

Numerous preclinical animal studies have demonstrated promising results regarding the regenerative properties of TB-500. However, clinical trials in humans remain scarce, and the scientific evidence supporting its therapeutic use in humans is currently limited. Ongoing research is focusing on cardiac disease, wound healing, and neurodegenerative conditions as primary areas of interest.

References

Goldstein AL, Kleinman HK. - Advances in the basic and clinical applications of thymosin beta-4. - Expert Opinion on Biological Therapy, 2011.
Philp D, Kleinman HK. - Animal studies with thymosin beta-4, a multifunctional tissue repair and regeneration peptide. - Annals of the New York Academy of Sciences, 2010.
World Anti-Doping Agency (WADA) - Prohibited List 2024. - www.wada-ama.org

Building Blocks for a Healthy Life

As an integrated manufacturer, we develop & produce evidence-based, patented, and non-patented formulations. We work exclusively with plant and natural extracts according to the strictest purity & quality standards.
The combination of science & modern technology with the laws of nature creates solutions consistently tailored to humans – for the highest good: health.

Most read entries

3 Posts in this encyclopedia category